Acrux Limited (ARUXF)
OTCMKTS · Delayed Price · Currency is USD
0.0045
-0.0118 (-72.39%)
At close: Jan 8, 2026
Acrux Revenue
In the fiscal year ending June 30, 2025, Acrux had annual revenue of 1.19M AUD, down -76.63%. Acrux had revenue of 1.07M in the half year ending June 30, 2025, a decrease of -84.73%.
Revenue
1.19M AUD
Revenue Growth
-76.63%
P/S Ratio
5.62
Revenue / Employee
27.67K AUD
Employees
43
Market Cap
4.38M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.19M | -3.90M | -76.63% |
| Jun 30, 2024 | 5.09M | -3.34M | -39.60% |
| Jun 30, 2023 | 8.43M | 6.71M | 390.34% |
| Jun 30, 2022 | 1.72M | 382.00K | 28.57% |
| Jun 30, 2021 | 1.34M | 84.00K | 6.70% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Clearside Biomedical | 3.33M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| AXIM Biotechnologies | 92.90K |
| Enzon Pharmaceuticals | 26.00K |